title: Loss of gender difference in serum leptin levels and its slow recovery after successful surgery for Leydig cell tumours in two virilized females.
abstract: One of the factors that predicts serum leptin levels is gender. It has been shown that sex steroid hormones, in particular testosterone, play an important role in the regulation of serum leptin levels. We had the opportunity to examine the effects of acute and chronic changes in serum testosterone levels on serum leptin concentrations in two virilized females harbouring testosterone-secreting ovarian tumours, before and after curative surgery. Chronically elevated basal testosterone levels (46 nmol/l) were associated with suppressed serum leptin levels (1.46 microg/l and 2.56 microg/l) vs. 12 age- and BMI-matched healthy subjects 9.89 +/- 0.64 microg/l. Leptin levels were determined from pooled serum samples assayed by commercial radioimmunoassay. High testosterone levels abolished the well known sexual dimorphism of serum leptin levels. Two weeks after curative resection of these tumours serum leptin levels were unaltered and started to increase progressively after one month. One patient received parenteral conjugated oestrogens while the other resumed spontaneous menstrual cycles. Three months after curative surgery obvious changes in body composition were registered (DEXA). Six months later further rise in serum leptin concentrations occurred without further changes in body composition. In conclusion, leptin levels did not change in spite of rapid changes in the steroid milieu, but in the long term increase in body fat stores, new steroid milieu and maybe other factors are important determining factors of serum leptin levels.
authors.affiliation: Institute of Endocrinology, University Clinical Center, Belgrade, Yugoslavia.
authors.forename: S
authors.initials: S
authors.lastname: Pekic
authors.forename: S
authors.initials: S
authors.lastname: Vujovic
authors.forename: S
authors.initials: S
authors.lastname: Spremovic-Radjenovic
authors.forename: M
authors.initials: M
authors.lastname: Petakov
authors.forename: M
authors.initials: M
authors.lastname: Djurovic
authors.forename: S
authors.initials: S
authors.lastname: Damjanovic
authors.forename: D
authors.initials: D
authors.lastname: Micic
authors.forename: C
authors.initials: C
authors.lastname: Dieguez
authors.forename: F F
authors.initials: FF
authors.lastname: Casanueva
authors.forename: V
authors.initials: V
authors.lastname: Popovic
mesh_terms: D000328:Adult; D001823:Body Composition; D016022:Case-Control Studies; D005260:Female; D006801:Humans; D020738:Leptin / Q000097:blood*; D007984:Leydig Cell Tumor / Q000097:blood* / Q000378:metabolism / Q000601:surgery; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000097:blood* / Q000378:metabolism / Q000601:surgery; D011184:Postoperative Period; D012727:Sex Characteristics; D013739:Testosterone / Q000097:blood / Q000378:metabolism; D014770:Virilism / Q000097:blood* / Q000209:etiology
chemical_list: D020738:Leptin; D013739:Testosterone